336 related articles for article (PubMed ID: 14563701)
1. Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells.
Kim J; Adam RM; Solomon KR; Freeman MR
Endocrinology; 2004 Feb; 145(2):613-9. PubMed ID: 14563701
[TBL] [Abstract][Full Text] [Related]
2. Cytokine signaling: STATS in plasma membrane rafts.
Sehgal PB; Guo GG; Shah M; Kumar V; Patel K
J Biol Chem; 2002 Apr; 277(14):12067-74. PubMed ID: 11815625
[TBL] [Abstract][Full Text] [Related]
3. Polarity and lipid raft association of the components of the ciliary neurotrophic factor receptor complex in Madin-Darby canine kidney cells.
Buk DM; Waibel M; Braig C; Martens AS; Heinrich PC; Graeve L
J Cell Sci; 2004 Apr; 117(Pt 10):2063-75. PubMed ID: 15054106
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation.
Wang Q; Horiatis D; Pinski J
Int J Cancer; 2004 Sep; 111(4):508-13. PubMed ID: 15239127
[TBL] [Abstract][Full Text] [Related]
6. Interactions of STAT3 with caveolin-1 and heat shock protein 90 in plasma membrane raft and cytosolic complexes. Preservation of cytokine signaling during fever.
Shah M; Patel K; Fried VA; Sehgal PB
J Biol Chem; 2002 Nov; 277(47):45662-9. PubMed ID: 12235142
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.
Deeble PD; Murphy DJ; Parsons SJ; Cox ME
Mol Cell Biol; 2001 Dec; 21(24):8471-82. PubMed ID: 11713282
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST).
Zhu Y; Liu C; Cui Y; Nadiminty N; Lou W; Gao AC
Prostate; 2014 Aug; 74(11):1086-94. PubMed ID: 24819501
[TBL] [Abstract][Full Text] [Related]
9. Activation of the Erk mitogen-activated protein kinase pathway stimulates neuroendocrine differentiation in LNCaP cells independently of cell cycle withdrawal and STAT3 phosphorylation.
Kim J; Adam RM; Freeman MR
Cancer Res; 2002 Mar; 62(5):1549-54. PubMed ID: 11888934
[TBL] [Abstract][Full Text] [Related]
10. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
Sanford DC; DeWille JW
Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
[TBL] [Abstract][Full Text] [Related]
11. Different associations of CD45 isoforms with STAT3, PKC and ERK regulate IL-6-induced proliferation in myeloma.
Zheng X; Li AS; Zheng H; Zhao D; Guan D; Zou H
PLoS One; 2015; 10(3):e0119780. PubMed ID: 25781885
[TBL] [Abstract][Full Text] [Related]
12. Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype.
Zelivianski S; Verni M; Moore C; Kondrikov D; Taylor R; Lin MF
Biochim Biophys Acta; 2001 May; 1539(1-2):28-43. PubMed ID: 11389966
[TBL] [Abstract][Full Text] [Related]
13. STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .
Spiotto MT; Chung TD
Prostate; 2000 Feb; 42(3):186-95. PubMed ID: 10639189
[TBL] [Abstract][Full Text] [Related]
14. IL-6 induces neuroendocrine dedifferentiation and cell proliferation in non-small cell lung cancer cells.
Chang KT; Tsai CM; Chiou YC; Chiu CH; Jeng KS; Huang CY
Am J Physiol Lung Cell Mol Physiol; 2005 Sep; 289(3):L446-53. PubMed ID: 15894558
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway.
Lee SO; Lou W; Johnson CS; Trump DL; Gao AC
Prostate; 2004 Aug; 60(3):178-86. PubMed ID: 15176047
[TBL] [Abstract][Full Text] [Related]
16. Preformed STAT3 transducer complexes in human HepG2 cells and rat hepatocytes.
Dráber P; Dráberová L; Heneberg P; Smíd F; Farghali H; Dráber P
Cell Signal; 2007 Nov; 19(11):2400-12. PubMed ID: 17716862
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of lipid rafts with different properties from RBL-2H3 (rat basophilic leukaemia) cells.
Radeva G; Sharom FJ
Biochem J; 2004 May; 380(Pt 1):219-30. PubMed ID: 14769131
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway .
Lou W; Ni Z; Dyer K; Tweardy DJ; Gao AC
Prostate; 2000 Feb; 42(3):239-42. PubMed ID: 10639195
[TBL] [Abstract][Full Text] [Related]
19. Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts).
Waheed AA; Shimada Y; Heijnen HF; Nakamura M; Inomata M; Hayashi M; Iwashita S; Slot JW; Ohno-Iwashita Y
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4926-31. PubMed ID: 11309501
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
